Cargando…

Italian association for the study of the liver position statement on SARS-CoV2 vaccination

The vaccination campaign against Sars-CoV-2 commenced in Italy at the end of December 2020. The first ones to receive the immunization against the virus were the health workers and the residents of nursing homes, following which the vaccine would be available for the entire population, beginning wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Russo, Francesco Paolo, Piano, Salvatore, Bruno, Raffaele, Burra, Patrizia, Puoti, Massimo, Masarone, Mario, Montagnese, Sara, Ponziani, Francesca Romana, Petta, Salvatore, Aghemo, Alessio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8086184/
https://www.ncbi.nlm.nih.gov/pubmed/33941488
http://dx.doi.org/10.1016/j.dld.2021.03.013
_version_ 1783686473160065024
author Russo, Francesco Paolo
Piano, Salvatore
Bruno, Raffaele
Burra, Patrizia
Puoti, Massimo
Masarone, Mario
Montagnese, Sara
Ponziani, Francesca Romana
Petta, Salvatore
Aghemo, Alessio
author_facet Russo, Francesco Paolo
Piano, Salvatore
Bruno, Raffaele
Burra, Patrizia
Puoti, Massimo
Masarone, Mario
Montagnese, Sara
Ponziani, Francesca Romana
Petta, Salvatore
Aghemo, Alessio
author_sort Russo, Francesco Paolo
collection PubMed
description The vaccination campaign against Sars-CoV-2 commenced in Italy at the end of December 2020. The first ones to receive the immunization against the virus were the health workers and the residents of nursing homes, following which the vaccine would be available for the entire population, beginning with the most vulnerable individuals. SARS-CoV2 vaccines have been demonstrated to be safe for the general population, although no data for patients with liver diseases or those having undergone liver transplantation are available so far. The present position statement AISF is an attempt to suggest, based on the published data on the impact of Sars-Cov-2 infection in patients with chronic liver disease, a possible priority for vaccination for this category of patients.
format Online
Article
Text
id pubmed-8086184
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-80861842021-05-03 Italian association for the study of the liver position statement on SARS-CoV2 vaccination Russo, Francesco Paolo Piano, Salvatore Bruno, Raffaele Burra, Patrizia Puoti, Massimo Masarone, Mario Montagnese, Sara Ponziani, Francesca Romana Petta, Salvatore Aghemo, Alessio Dig Liver Dis Position Paper The vaccination campaign against Sars-CoV-2 commenced in Italy at the end of December 2020. The first ones to receive the immunization against the virus were the health workers and the residents of nursing homes, following which the vaccine would be available for the entire population, beginning with the most vulnerable individuals. SARS-CoV2 vaccines have been demonstrated to be safe for the general population, although no data for patients with liver diseases or those having undergone liver transplantation are available so far. The present position statement AISF is an attempt to suggest, based on the published data on the impact of Sars-Cov-2 infection in patients with chronic liver disease, a possible priority for vaccination for this category of patients. Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. 2021-06 2021-04-30 /pmc/articles/PMC8086184/ /pubmed/33941488 http://dx.doi.org/10.1016/j.dld.2021.03.013 Text en © 2021 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Position Paper
Russo, Francesco Paolo
Piano, Salvatore
Bruno, Raffaele
Burra, Patrizia
Puoti, Massimo
Masarone, Mario
Montagnese, Sara
Ponziani, Francesca Romana
Petta, Salvatore
Aghemo, Alessio
Italian association for the study of the liver position statement on SARS-CoV2 vaccination
title Italian association for the study of the liver position statement on SARS-CoV2 vaccination
title_full Italian association for the study of the liver position statement on SARS-CoV2 vaccination
title_fullStr Italian association for the study of the liver position statement on SARS-CoV2 vaccination
title_full_unstemmed Italian association for the study of the liver position statement on SARS-CoV2 vaccination
title_short Italian association for the study of the liver position statement on SARS-CoV2 vaccination
title_sort italian association for the study of the liver position statement on sars-cov2 vaccination
topic Position Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8086184/
https://www.ncbi.nlm.nih.gov/pubmed/33941488
http://dx.doi.org/10.1016/j.dld.2021.03.013
work_keys_str_mv AT russofrancescopaolo italianassociationforthestudyoftheliverpositionstatementonsarscov2vaccination
AT pianosalvatore italianassociationforthestudyoftheliverpositionstatementonsarscov2vaccination
AT brunoraffaele italianassociationforthestudyoftheliverpositionstatementonsarscov2vaccination
AT burrapatrizia italianassociationforthestudyoftheliverpositionstatementonsarscov2vaccination
AT puotimassimo italianassociationforthestudyoftheliverpositionstatementonsarscov2vaccination
AT masaronemario italianassociationforthestudyoftheliverpositionstatementonsarscov2vaccination
AT montagnesesara italianassociationforthestudyoftheliverpositionstatementonsarscov2vaccination
AT ponzianifrancescaromana italianassociationforthestudyoftheliverpositionstatementonsarscov2vaccination
AT pettasalvatore italianassociationforthestudyoftheliverpositionstatementonsarscov2vaccination
AT aghemoalessio italianassociationforthestudyoftheliverpositionstatementonsarscov2vaccination
AT italianassociationforthestudyoftheliverpositionstatementonsarscov2vaccination